Your cart is currently empty.
Weight loss has always been a struggle for millions—but that’s rapidly changing thanks to GLP-1 medications like Mounjaro and Ozempic. Originally designed to treat type 2 diabetes, both drugs are now helping patients shed weight safely and steadily, even without a diabetes diagnosis.
As more people turn to medical weight loss in 2025, the comparison between Mounjaro and Ozempic has become essential. Here’s how both are transforming the landscape—and what you need to know if you’re considering one over the other.
How They Work: GLP-1 vs. Dual Agonist
- Ozempic contains semaglutide, a GLP-1 receptor agonist. It reduces hunger, slows digestion, and helps regulate blood sugar.
- Mounjaro contains tirzepatide, a dual GIP and GLP-1 agonist. It acts on two pathways instead of one, which may result in even greater appetite control and fat loss.
The dual-action of Mounjaro often leads to faster and more profound results—but both drugs are clinically proven to support sustainable weight loss.
Weight Loss Results: What to Expect
Most patients on either medication experience:
- Reduced cravings and appetite in the first 1–2 weeks
- Gradual but consistent weight loss of 1–3 pounds per week
- Improved metabolic health (insulin sensitivity, lower inflammation)
- Better portion control without intense dieting
In clinical trials:
- Ozempic users lost up to 15% of body weight over time
- Mounjaro users reported losses of 20% or more in some studies
While results vary, both medications are outperforming traditional methods like keto, calorie counting, or appetite suppressants.
Price Without Insurance: What It Really Costs
Retail pharmacy prices remain high:
- Ozempic: Around $1,300–$1,500/month
- Mounjaro: Similar pricing, often $1,200–$1,400/month
Most insurance plans still don’t cover GLP-1 medications for weight loss unless the patient is diabetic. That’s where telehealth has completely changed the game.
The Affordable Telehealth Solution
Telehealth providers like Meya now offer compounded semaglutide and tirzepatide—same active ingredients, but at a much lower cost.
With Meya, you get:
- Online medical evaluation
- Licensed provider review
- Monthly supply of compounded GLP-1 medication
- Flat pricing at just $196/month
- No insurance, no pharmacy lines
This approach removes all the barriers: cost, access, and wait times.
Why These Medications Are Redefining Weight Loss in 2025
Here’s what sets GLP-1 treatments apart:
- Science-backed results that beat traditional dieting
- No intense exercise or meal replacement plans required
- Real behavioral change through appetite and hormonal control
- Telehealth access that makes care more affordable and convenient
Patients who once failed on other programs are now seeing consistent, manageable weight loss without extreme restrictions.
Conclusion: Mounjaro vs Ozempic Is the Future of Fat Loss
Whether you choose Mounjaro or Ozempic, both are revolutionizing the way we approach weight loss. With support from telehealth platforms, access is easier—and results are more achievable—than ever before.
Want real GLP-1 treatment without the $1,300/month price tag? Start your journey with Meya for just $196/month.
